GlassScriptPhysician profile
Frank J Andres
NPI 1720071475
$1,163.75
in general payments reported to CMS, 2019-2025
20 companies · $86.60 in 2025
The $86.60 reported for 2025 was less than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $250 · 2020: $122 · 2021: $458 · 2022: $94.58 · 2023: $76.08 · 2024: $76.71 · 2025: $86.60.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $239.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $239.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $266.59 | 2019-2021 | |
| Astellas Pharma US INC | $201.43 | 2019-2021 | |
| Evofem Biosciences, INC. | $134.85 | 2021-2024 | |
| Hologic Sales and Service, LLC | $115.65 | 2019-2025 | Aptima |
| Boston Scientific Corporation | $68.13 | 2023-2025 | Solyx Sis System, Lynx System |
| Exeltis, USA INC. | $61.03 | 2021-2023 | Slynd |
| Millicent US INC | $45.77 | 2024-2025 | Intrarosa |
| Lupin INC. | $41.10 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $38.80 | 2021 | |
| Covidien LP | $29.08 | 2019 | |
| Avion Pharmaceuticals | $28.71 | 2020-2021 | |
| Urovant Sciences INC | $23.03 | 2022 | |
| Mayne Pharma Commercial LLC | $20.15 | 2021 | |
| Laborie Medical Technologies Corp. | $17.59 | 2025 | Flowstar |
| Pfizer INC. | $17.01 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $15.80 | 2023 | Axonics |
| Agile Therapeutics, INC. | $13.17 | 2021 | |
| Allergan, INC. | $13.09 | 2020 | |
| Minerva Surgical, INC | $12.77 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frank Andres listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.